[HTML][HTML] Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis
I Michelon, M Vilbert, AD Marinho, CER Castro… - ESMO open, 2024 - Elsevier
Background Trastuzumab deruxtecan (T-DXd) has shown promising results in patients with
breast cancer brain metastases (BCBMs). We conducted a systematic review and meta …
breast cancer brain metastases (BCBMs). We conducted a systematic review and meta …